Overview

Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Periodic Limb Movements (PLMs) during sleep in patients with Restless Legs Syndrome (RLS) have been shown to be associated with elevations in Blood Pressure (BP). Rotigotine has been shown to effectively reduce the incidence of PLMs in patients with RLS. The current study aims to demonstrate that treatment with Rotigotine could help reduce the number of nocturnal BP elevations associated with PLMs in patients with RLS.
Phase:
Phase 4
Details
Lead Sponsor:
UCB BIOSCIENCES GmbH
Treatments:
N 0437
Rotigotine